NCT02669940View on ClinicalTrials.gov

Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation

CompletedOBSERVATIONAL

Enrollment

158

Participants

Timeline

Start Date

April 15, 2016

Primary Completion Date

July 4, 2017

Study Completion Date

July 4, 2017

Conditions

Chronic Hepatitis CGenotype 1

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AbbVie

INDUSTRY

NCT02669940 - Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation | Biotech Hunter | Biotech Hunter